Anthony A. Rayner

3.7k citations
42 papers · 2.8k · 1 hit paper · h-index 22

Impact in

  • Immunology top 2%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Cancer Immunotherapy and Biomarkers 10
    • CAR-T cell therapy research 10
    • Pancreatic and Hepatic Oncology Research 3
    • Immune Cell Function and Interaction 13
    • Immunotherapy and Immune Responses 9

Anthony A. Rayner

41 papers receiving 2.7k citations

Anthony A. Rayner's Hit Papers

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. 1985 · 488 citations
4880+13+27Years since publication100200300400

Peers

Anthony A. Rayner
Comparison fields: 5 of 124
  • Immunology 1.3k
  • Hepatology 431
  • Oncology 1.3k
  • Hematology 175
  • Biotechnology 114
Replace Bernard Charpentier with:
Bernard Charpentier France
Michael Lahn United States
Matthew H. Levine United States
Jacek Roliński Poland
Norio Yoshimura Japan
Jonathan Spicer Canada
Thomas Barnetche France
Josette Eris Australia
FC Breedveld Netherlands
Stefan Serke Germany
Anthony A. Rayner relative to Bernard Charpentier France Bernard Charpentier's profile →
Citations per field
00.5×8.8×
Bernard Charpentier · 1×
Citations per year

Countries citing papers authored by Anthony A. Rayner

Since Specialization
Citations

This map shows the geographic impact of Anthony A. Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony A. Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony A. Rayner more than expected).

Fields of papers citing papers by Anthony A. Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony A. Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony A. Rayner. The network helps show where Anthony A. Rayner may publish in the future.

Co-authors

The 25 scholars most cited alongside Anthony A. Rayner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anthony A. Rayner Line = papers co-authored together Anthony A. Rayner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
Hit paper breakdown →
1985488
2 1989349
3 1986288
4 1989260
5 1990163
6
Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
1988157
7 1981102
8 198599
9 198697
10 198795
11 199167
12
Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans.
198867
13 199066
14 199066
15 198562
16 199057
17 201747
18 198641
19 198740
20 198526

About Anthony A. Rayner

Anthony A. Rayner is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 42 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (10 papers), Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Gastric Cancer Management and Outcomes (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Immunology (1.3k citations), Hepatology (431 citations), Oncology (1.3k citations), Hematology (175 citations) and Biotechnology (114 citations). Anthony A. Rayner has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Michael T. Lotze, Steven A. Rosenberg, Stephen E. Ettinghausen, Yvedt L. Matory, Claudia A. Seipp, B.J. Lewis, Brett T. Gemlo, Robert Stagg, S O Sharrow and Mary Custer. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Cancer, Journal of Surgical Oncology and The American Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact